<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ali I</submitter><funding>King Saud University</funding><pagination>e0294511</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10653426</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(11)</volume><pubmed_abstract>Cardiovascular disorders are the world's major cause of death nowadays. To treat cardiovascular diseases especially coronary artery diseases and hypertension, researchers found potential ROCK2 (Rho-associated coiled-coil-containing protein kinase 2) target due to its substantial role in NO-cGMP and RhoA/ROCK pathway. Available drugs for ROCK2 are less effective and some of them depict side effects. Therefore, a set of novel compounds were screened that can potentially inhibit the activity of ROCK2 and help to treat cardiovascular diseases by employing In-silico techniques. In this study, we undertook ligand based virtual screening of 50 million compound's library, to that purpose shape and features (contain functional groups) based pharmacophore query was modelled and validated by Area Und</pubmed_abstract><journal>PloS one</journal><pubmed_title>Computational exploration of novel ROCK2 inhibitors for cardiovascular disease management; insights from high-throughput virtual screening, molecular docking, DFT and MD simulation.</pubmed_title><pmcid>PMC10653426</pmcid><funding_grant_id>RSP2023R332</funding_grant_id><pubmed_authors>Ali I</pubmed_authors><pubmed_authors>Haq IU</pubmed_authors><pubmed_authors>Alonazi WB</pubmed_authors><pubmed_authors>Iqbal MN</pubmed_authors><pubmed_authors>Siddiqi AR</pubmed_authors><pubmed_authors>Ibrahim M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computational exploration of novel ROCK2 inhibitors for cardiovascular disease management; insights from high-throughput virtual screening, molecular docking, DFT and MD simulation.</name><description>Cardiovascular disorders are the world's major cause of death nowadays. To treat cardiovascular diseases especially coronary artery diseases and hypertension, researchers found potential ROCK2 (Rho-associated coiled-coil-containing protein kinase 2) target due to its substantial role in NO-cGMP and RhoA/ROCK pathway. Available drugs for ROCK2 are less effective and some of them depict side effects. Therefore, a set of novel compounds were screened that can potentially inhibit the activity of ROCK2 and help to treat cardiovascular diseases by employing In-silico techniques. In this study, we undertook ligand based virtual screening of 50 million compound's library, to that purpose shape and features (contain functional groups) based pharmacophore query was modelled and validated by Area Und</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-04-29T02:27:28.706Z</modification><creation>2025-02-19T01:19:03.186Z</creation></dates><accession>S-EPMC10653426</accession><cross_references><pubmed>37972144</pubmed><doi>10.1371/journal.pone.0294511</doi></cross_references></HashMap>